Neurocrine Biosciences Inc (NASDAQ:NBIX)

16.44
Data as of 1:56pm ET
 +0.12 / +0.74%
Today’s Change
8.57
Today|||52-Week Range
20.29
+76.02%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$1.2B

Company Description

Neurocrine Biosciences, Inc. operates as a product based biopharmaceutical company, which discovers, develops and intends to commercialize drugs for the treatment of neurological and endocrine related diseases and disorders. The company was founded by Kevin C. Gorman and Wylie W. Vale in January 1992 and is headquartered in San Diego, CA.

Contact Information

Neurocrine Biosciences, Inc.
12780 El Camino Real
San Diego California 92130
P:(858) 617-7600
Investor Relations:

Employees

Shareholders

Individual stakeholders9.73%
Mutual fund holders63.54%
Other institutional30.52%

Top Executives

Kevin C. GormanPresident, Chief Executive Officer & Director
Bill WilsonVice President-Information Technology & Operations
Timothy P. CoughlinChief Financial Officer
Dimitri E. GrigoriadisChief Research Officer
Christopher Flint O'BrienChief Medical Officer

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.